Tema Oncology ETF (CANC) is an ETF managed by Independent / Boutique. Its largest position is Revolution Medicines, Inc. (RVMD), representing 6.29% of fund assets.
Tema Oncology ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CANC
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 23, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Revolution Medicines, Inc.
|
6.29% | $10,057,233.62 | 98,581 |
|
-
APPLIED MATERIALS INC /DE
|
4.96% | $7,923,862.91 | 46,684 |
|
-
BridgeBio Pharma, Inc.
|
4.75% | $7,599,860.64 | 114,318 |
|
-
ASTRAZENECA PLC
|
4.63% | $7,397,860.46 | 35,320 |
|
-
ELI LILLY & Co
|
4.32% | $6,906,314.35 | 6,565 |
|
-
BRISTOL MYERS SQUIBB CO
|
4.22% | $6,747,623.19 | 108,187 |
|
-
ROCHE HOLDING AG
|
4.06% | $6,488,091.60 | 108,952 |
|
-
Merck & Co., Inc.
|
3.84% | $6,145,186.60 | 49,630 |
|
-
ARCELLX INC
|
3.44% | $5,501,291.34 | 48,346 |
|
-
Cogent Biosciences, Inc.
|
3.29% | $5,258,658.30 | 135,358 |
|
-
NUVALENT INC-A
|
3.14% | $5,019,916.05 | 49,239 |
|
-
GENMAB A/S
|
3.13% | $4,996,674.56 | 169,724 |
|
-
Immunome Inc.
|
2.67% | $4,272,558.86 | 195,451 |
|
-
JOHNSON & JOHNSON
|
2.53% | $4,038,726.51 | 16,257 |
|
-
Celcuity Inc.
|
2.47% | $3,951,294.41 | 35,371 |
|
-
AMGEN INC
|
2.46% | $3,928,955.52 | 10,122 |
|
-
AbbVie Inc.
|
2.43% | $3,878,520.96 | 16,712 |
|
-
EXELIXIS, INC.
|
2.19% | $3,508,894.34 | 79,639 |
|
-
IDEAYA Biosciences, Inc.
|
1.80% | $2,873,463.60 | 89,238 |
|
-
BeOne Medicines Ltd.
|
1.78% | $2,840,230.40 | 8,960 |
|
-
Syndax Pharmaceuticals Inc
|
1.73% | $2,764,833.63 | 127,353 |
|
-
CG Oncology, Inc.
|
1.69% | $2,698,038.00 | 45,885 |
|
-
Zai Lab Ltd
|
1.46% | $2,330,982.38 | 121,279 |
|
-
Erasca, Inc.
|
1.45% | $2,315,192.42 | 169,487 |
|
-
Zymeworks Inc.
|
1.41% | $2,252,678.67 | 96,723 |
|
-
Legend Biotech Corp
|
1.37% | $2,192,771.00 | 115,409 |
|
-
Nuvation Bio Inc.
|
1.34% | $2,139,691.86 | 362,046 |
|
-
HALOZYME THERAPEUTICS, INC.
|
1.30% | $2,076,722.04 | 29,868 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
1.28% | $2,052,102.97 | 30,652 |
|
-
Summit Therapeutics Inc.
|
1.15% | $1,840,129.62 | 110,918 |
|
-
ANAPTYSBIO, INC
|
0.99% | $1,577,567.85 | 28,657 |
|
-
Nurix Therapeutics, Inc.
|
0.97% | $1,557,953.35 | 97,555 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
0.97% | $1,549,269.94 | 1,982 |
|
-
Corvus Pharmaceuticals, Inc.
|
0.94% | $1,500,022.48 | 82,148 |
|
-
UroGen Pharma Ltd.
|
0.91% | $1,457,458.80 | 67,164 |
|
-
Relay Therapeutics, Inc.
|
0.91% | $1,457,330.40 | 142,040 |
|
-
GILEAD SCIENCES, INC.
|
0.86% | $1,381,064.40 | 9,272 |
|
-
Olema Pharmaceuticals, Inc.
|
0.86% | $1,369,913.60 | 56,608 |
|
-
DAY ONE BIOPHARMACEUTICALS INC
|
0.81% | $1,292,436.80 | 121,928 |
|
-
ARGENX SE
|
0.80% | $1,275,387.96 | 1,663 |
|
-
TERNS PHARMACEUTICALS INC
|
0.74% | $1,180,118.16 | 28,018 |
|
-
FIRST AMERICAN TREASURY OBLIGA
|
0.64% | $1,026,900.56 | 1,026,901 |
|
-
Xencor Inc
|
0.61% | $982,370.56 | 76,928 |
|
-
Tyra Biosciences, Inc.
|
0.59% | $947,269.78 | 28,438 |
|
-
Guardant Health, Inc.
|
0.59% | $939,751.20 | 10,008 |
|
-
Arcus Biosciences, Inc.
|
0.59% | $936,062.61 | 45,953 |
|
-
ArriVent BioPharma, Inc.
|
0.59% | $935,866.71 | 40,743 |
|
-
Immunocore Holdings plc
|
0.57% | $913,282.50 | 28,275 |
|
-
HUTCHMED (China) Ltd
|
0.56% | $890,308.57 | 62,129 |
|
-
Monte Rosa Therapeutics, Inc.
|
0.51% | $808,051.00 | 45,524 |
Advertisement (320x50)